Published in Oncotarget on June 07, 2016
Neurofibrillary tangles in Alzheimer's disease: elucidation of the molecular mechanism by immunohistochemistry and tau protein phospho-proteomics. Neural Regen Res (2016) 0.75
Chronic low-dose-rate ionising radiation affects the hippocampal phosphoproteome in the ApoE-/- Alzheimer's mouse model. Oncotarget (2016) 0.75
Differentially expressed lncRNAs and miRNAs with associated ceRNA networks in aged mice with postoperative cognitive dysfunction. Oncotarget (2017) 0.75
Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (1991) 49.03
ProteomeXchange provides globally coordinated proteomics data submission and dissemination. Nat Biotechnol (2014) 13.40
Highly selective enrichment of phosphorylated peptides from peptide mixtures using titanium dioxide microcolumns. Mol Cell Proteomics (2005) 6.34
Silver staining of Alzheimer's neurofibrillary changes by means of physical development. Acta Morphol Acad Sci Hung (1971) 3.71
Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus. Neuroreport (2007) 3.70
DIANA miRPath v.2.0: investigating the combinatorial effect of microRNAs in pathways. Nucleic Acids Res (2012) 3.67
Micro-RNA abundance and stability in human brain: specific alterations in Alzheimer's disease temporal lobe neocortex. Neurosci Lett (2009) 2.75
Role of Septin cytoskeleton in spine morphogenesis and dendrite development in neurons. Curr Biol (2007) 2.60
Novel protein serine/threonine phosphatases: variety is the spice of life. Trends Biochem Sci (1997) 2.54
Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities. Neurobiol Dis (2005) 2.22
Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: In vitro and in vivo mechanisms related to Alzheimer's disease. J Neurosci (2001) 2.15
P38 MAP kinase is activated at early stages in Alzheimer's disease brain. Exp Neurol (2003) 2.14
Regulation of hippocampal synaptic plasticity by cyclic AMP-dependent protein kinases. Prog Neurobiol (2003) 2.06
SIMAC (sequential elution from IMAC), a phosphoproteomics strategy for the rapid separation of monophosphorylated from multiply phosphorylated peptides. Mol Cell Proteomics (2007) 1.98
Microglia protect neurons against ischemia by synthesis of tumor necrosis factor. J Neurosci (2009) 1.97
The mitogen-activated protein kinase cascade couples PKA and PKC to cAMP response element binding protein phosphorylation in area CA1 of hippocampus. J Neurosci (1999) 1.94
MicroRNA regulation of Alzheimer's Amyloid precursor protein expression. Neurobiol Dis (2008) 1.89
Hydrophilic interaction chromatography reduces the complexity of the phosphoproteome and improves global phosphopeptide isolation and detection. Mol Cell Proteomics (2008) 1.88
Specific activation of microRNA106b enables the p73 apoptotic response in chronic lymphocytic leukemia by targeting the ubiquitin ligase Itch for degradation. Blood (2008) 1.87
MicroRNA-146a: a key regulator of astrocyte-mediated inflammatory response. PLoS One (2012) 1.59
Exploring the sialiome using titanium dioxide chromatography and mass spectrometry. Mol Cell Proteomics (2007) 1.38
MicroRNA-101 regulates amyloid precursor protein expression in hippocampal neurons. J Biol Chem (2010) 1.33
Retinoic acid attenuates beta-amyloid deposition and rescues memory deficits in an Alzheimer's disease transgenic mouse model. J Neurosci (2008) 1.30
Impaired phosphorylation of cyclic AMP response element binding protein in the hippocampus of dementia of the Alzheimer type. Brain Res (1999) 1.24
CREB phosphorylation as a molecular marker of memory processing in the hippocampus for spatial learning. Behav Brain Res (2002) 1.20
Increased expression of miRNA-146a in Alzheimer's disease transgenic mouse models. Neurosci Lett (2010) 1.19
Regulation of microtubule dynamic instability in vitro by differentially phosphorylated stathmin. J Biol Chem (2009) 1.18
Insulin-like growth factor 1 is essential for normal dendritic growth. J Neurosci Res (2003) 1.17
Microtubule dynamics: if you need a shrink try stathmin/Op18. Curr Biol (1998) 1.16
APP processing and amyloid deposition in mice haplo-insufficient for presenilin 1. Neurobiol Aging (2004) 1.15
Imaging polyglutamine deposits in brain tissue. Methods Enzymol (2006) 1.13
Non-coding RNAs in Alzheimer's disease. Mol Neurobiol (2012) 1.08
Phosphorylated cAMP response element-binding protein as a molecular marker of memory processing in rat hippocampus: effect of novelty. J Neurosci (2000) 1.07
Olfactory bulb involvement in neurodegenerative diseases. Acta Neuropathol (2014) 1.05
Insulin-like growth factor 1 and 2 (IGF1, IGF2) expression in human microglia: differential regulation by inflammatory mediators. J Neuroinflammation (2013) 1.04
Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer's disease. Alzheimers Dement (2014) 1.04
Microglial derived tumor necrosis factor-α drives Alzheimer's disease-related neuronal cell cycle events. Neurobiol Dis (2013) 1.02
Pathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body disease. Biochem Pharmacol (2014) 1.01
Models of β-amyloid induced Tau-pathology: the long and "folded" road to understand the mechanism. Mol Neurodegener (2014) 0.99
Relative abundance of tau and neurofilament epitopes in hippocampal neurofibrillary tangles. Am J Pathol (1990) 0.99
The microtubule destabilizer stathmin mediates the development of dendritic arbors in neuronal cells. J Cell Sci (2007) 0.98
Contribution of the neural cell adhesion molecule to neuronal and synaptic plasticity. Rev Neurosci (2001) 0.96
Low-dose ionizing radiation rapidly affects mitochondrial and synaptic signaling pathways in murine hippocampus and cortex. J Proteome Res (2015) 0.96
Early alterations in energy metabolism in the hippocampus of APPswe/PS1dE9 mouse model of Alzheimer's disease. Biochim Biophys Acta (2014) 0.95
The potential role of microRNA-146 in Alzheimer's disease: biomarker or therapeutic target? Med Hypotheses (2011) 0.95
Multidimensional strategy for sensitive phosphoproteomics incorporating protein prefractionation combined with SIMAC, HILIC, and TiO(2) chromatography applied to proximal EGF signaling. J Proteome Res (2011) 0.91
The cognitive defects of neonatally irradiated mice are accompanied by changed synaptic plasticity, adult neurogenesis and neuroinflammation. Mol Neurodegener (2014) 0.91
Neuroinflammatory signals in Alzheimer disease and APP/PS1 transgenic mice: correlations with plaques, tangles, and oligomeric species. J Neuropathol Exp Neurol (2015) 0.90
Changes in microtubule turnover accompany synaptic plasticity and memory formation in response to contextual fear conditioning in mice. Neuroscience (2010) 0.90
Neurobiology of Alzheimer's Disease: Integrated Molecular, Physiological, Anatomical, Biomarker, and Cognitive Dimensions. Curr Alzheimer Res (2015) 0.90
Amyloid generation and dysfunctional immunoproteasome activation with disease progression in animal model of familial Alzheimer's disease. Brain Pathol (2012) 0.89
Immunocytochemical localization of actin in dendritic spines of the cerebral cortex using colloidal gold as a probe. Cell Mol Neurobiol (1985) 0.89
Aβ and tau toxicities in Alzheimer's are linked via oxidative stress-induced p38 activation: protective role of vitamin E. Redox Biol (2014) 0.88
Comprehensive protocol to simultaneously study protein phosphorylation, acetylation, and N-linked sialylated glycosylation. Methods Mol Biol (2015) 0.86
Cytokine-producing microglia have an altered beta-amyloid load in aged APP/PS1 Tg mice. Brain Behav Immun (2015) 0.86
Decreased protein levels of stathmin in adult brains with Down syndrome and Alzheimer's disease. J Neural Transm Suppl (2001) 0.84
N-glycosylation in regulation of the nervous system. Adv Neurobiol (2014) 0.83
The biomarker and therapeutic potential of miRNA in Alzheimer's disease. Neurodegener Dis Manag (2015) 0.82
Microtubule destruction induces tau liberation and its subsequent phosphorylation. FEBS Lett (2010) 0.82
Probable participation of 14-3-3 in tau protein oligomerization and aggregation. J Alzheimers Dis (2011) 0.81
Interaction of 14-3-3ζ with microtubule-associated protein tau within Alzheimer's disease neurofibrillary tangles. Biochemistry (2013) 0.81
Role of synaptic activity in the regulation of amyloid beta levels in Alzheimer's disease. Neurobiol Aging (2013) 0.79
Aβ-dependent reduction of NCAM2-mediated synaptic adhesion contributes to synapse loss in Alzheimer's disease. Nat Commun (2015) 0.79
FRET and FRAP imaging: approaches to characterise tau and stathmin interactions with microtubules in cells. Biol Cell (2013) 0.78
Olfactory bulb proteome dynamics during the progression of sporadic Alzheimer's disease: identification of common and distinct olfactory targets across Alzheimer-related co-pathologies. Oncotarget (2015) 0.78
Cyclic adenosine monophosphate as an endogenous modulator of the amyloid-β precursor protein metabolism. IUBMB Life (2013) 0.78
The over-expression of the wild type or mutant forms of the presenilin-1 protein alters glycoprotein processing in a human neuroblastoma cell line. Neurosci Lett (2003) 0.78
Synaptic activity and Alzheimer's disease: a critical update. Front Neurosci (2015) 0.78
Profiling the human hippocampal proteome at all pathologic stages of Alzheimer's disease. Alzheimers Dement (2016) 0.77
Regulatory function of glycosphingolipids in the inflammation and degeneration. Arch Biochem Biophys (2015) 0.77
Simplification of the modified Gallyas method. Neuropathology (2014) 0.76